These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5558997)

  • 1. Rifampin: in vitro effect on atypical mycobacteria.
    Rynearson TK; Shronts JS; Wolinsky E
    Am Rev Respir Dis; 1971 Aug; 104(2):272-4. PubMed ID: 5558997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative in vitro activities of rifabutin and rifampicin against various mycobacteria using 7H10 agar and 1% Ogawa egg media].
    Sato K; Saito H; Tomioka H
    Kekkaku; 1988 Sep; 63(9):601-4. PubMed ID: 2854588
    [No Abstract]   [Full Text] [Related]  

  • 3. "In vitro" action of rifampicin on typical and atypical mycobacteria.
    Tanzil HO; Chatim A; Rachim A; Judanarso D
    Acta Tuberc Pneumol Belg; 1972; 63(1):140-7. PubMed ID: 4631816
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of atypical mycobacteria to rifampin.
    Molavi A; Weinstein L
    Appl Microbiol; 1971 Jul; 22(1):23-5. PubMed ID: 5111305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-vitro action of rifampicin on strains of tuberculous and atypical mycobacteria].
    Denis-Bottin C
    Acta Tuberc Pneumol Belg; 1972; 63(1):127-39. PubMed ID: 4631815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
    Mandler F; Garimoldi M
    G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of three mediums for rifampin-susceptibility tests of mycobacteria.
    Karlson AG
    Am Rev Respir Dis; 1970 May; 101(5):765-7. PubMed ID: 4986427
    [No Abstract]   [Full Text] [Related]  

  • 8. [Number of rifampicin- and ethambutol-resistant variants in strains of atypical mycobacteria pathogenic for man, on Loewenstein-Jensen media].
    Le Lirzin M; Boisvert H
    Ann Inst Pasteur (Paris); 1971 Apr; 120(4):549-59. PubMed ID: 5564197
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.
    Heifets LB
    Am Rev Respir Dis; 1982 Jan; 125(1):43-8. PubMed ID: 7065508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rifampicin sensitivity of mycobacteria].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR; Steingrube VA
    Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of Runyon Group I Mycobacteria to rifampicin.
    Saito H; Yamamoto S; Yamura T
    Hiroshima J Med Sci; 1972 Mar; 21(1):35-40. PubMed ID: 4661749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.
    Cynamon MH
    Antimicrob Agents Chemother; 1985 Sep; 28(3):440-1. PubMed ID: 4073865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of rifampin in dimethylsulfoxide.
    Karlson AG; Ulrich JA
    Appl Microbiol; 1969 Oct; 18(4):692-3. PubMed ID: 5369306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro susceptibility of mycobacteria to rifampin.
    McClatchy JK; Waggoner RF; Lester W
    Am Rev Respir Dis; 1969 Aug; 100(2):234-6. PubMed ID: 5805267
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
    Neubert R
    Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.